Fecal Biomarker Study for Patients With Ulcerative Colitis

A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD

NCT04079335 ·Status: UNKNOWN

Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population

NCT07177209 ·Status: ACTIVE_NOT_RECRUITING

Exacerbating Factors in Inflammatory Bowel Disease

NCT01405105 ·Status: COMPLETED

Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis

NCT07111572 ·Status: NOT_YET_RECRUITING

IBD Self-management Website and Home Faecal Calprotectin Monitoring

NCT03671980 ·Status: COMPLETED ·Phase: NA

Prospective Multicenter Trial to Determine the Efficacy and Outcome of the UCRI Biomarker Panel and Algorithm to Detect Mucosal Healing in Moderate to Severe Ulcerative Colitis Patients.

NCT04897282 ·Status: UNKNOWN

Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study

NCT03772145 ·Status: TERMINATED

Safety and Efficacy of QBECO in Moderate to Severe Ulcerative Colitis

NCT02426372 ·Status: COMPLETED ·Phase: PHASE2

Critical State of "Remission-Recurrence" of Ulcerative Colitis

NCT06694883 ·Status: RECRUITING

Pro-active Fecal Calprotectin Monitoring PROMOTE-UC

NCT03549988 ·Status: COMPLETED

Human and Microbial Determinants of the Onset of IBD Flares

NCT06967311 ·Status: RECRUITING

A Comparison of Once a Day Dose Compared to 2 Doses/Day

NCT00505778 ·Status: COMPLETED ·Phase: PHASE3

An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)

NCT05084261 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis

NCT03765450 ·Status: ACTIVE_NOT_RECRUITING

A Study of AC-101 Tablets in Participants With Moderate to Severe Active Ulcerative Colitis

NCT07083193 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Study to Evaluate the Epidemiology and the Characteristics "Omics" in Patients Recently Diagnosed of Inflammatory Bowel Disease in Spain

NCT03689257 ·Status: COMPLETED

Eicosapentaenoic Free Fatty Acid and Fecal Calprotectin in Inflammatory Bowel Diseases

NCT02179372 ·Status: COMPLETED ·Phase: NA

Prediction Model for Response to Biologics and Small Molecular Agent for UC

NCT05186623 ·Status: RECRUITING

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

NCT05782907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Phase 1b Study to Evaluate APL-1401 in Patients With Moderately to Severely Active Ulcerative Colitis

NCT05743010 ·Status: UNKNOWN ·Phase: PHASE1

MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach.

NCT04272307 ·Status: UNKNOWN

Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease

NCT05733845 ·Status: RECRUITING ·Phase: NA

Ulcerative Colitis Endoscopic Index of Severity and Fecal Calprotectin to Predict the Reaction to Corticosteroids of Acute Severe Ulcerative Colitis

NCT02922374 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

QuantiFERON-CMV Test in a Prediction for Colic Cytomegalovirus Reactivation During Ulcerative Colitis

NCT04030676 ·Status: RECRUITING ·Phase: NA

A Study of Moderate to Severe Inflammatory Bowel Disease, Including Ulcerative Colitis (UC) and Crohn's Disease (CD)

NCT04873700 ·Status: COMPLETED